Inflammatory lesions:
Highest efficacy obtained for the 5% BTX 1503 QD group (-11.8 lesions). This corresponds to an average percent reduction of 40.54%. The combined vehicle group result was -11.3 lesions or an average percent reduction of 40.15%.
Ann: Botanix Announces BTX 1503 Data and Progression to Phase 3, page-84
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.005(1.41%) |
Mkt cap ! $636.1M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 36.0¢ | 34.0¢ | $2.246M | 6.430M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 54114 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 80800 | 5 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |